Dose-Response Relationship Between Long-Term Blood Pressure Variability and Cognitive Decline

Stroke. 2021 Oct;52(10):3249-3257. doi: 10.1161/STROKEAHA.120.033697. Epub 2021 Jun 25.

Abstract

Background and purpose: We aimed to test whether higher long-term blood pressure variability was associated with accelerated rate of cognitive decline and evaluate potential dose-response relationship.

Methods: Original survey data from the Health and Retirement Study and the English Longitudinal Study of Ageing were used. Standardized Z score of cognitive function was the main outcome measure. Visit-to-visit blood pressure SD, coefficient of variation, and variation independent of mean were used. Linear mixed model and restricted spline were applied to assess association and explore dose-response pattern. Segmented regression was used to analyze dose-response relationship and estimate turning point. Meta-analysis using random-effects model was conducted to pool results, with I2 used to test heterogeneity.

Results: A total of 12 298 dementia-free participants were included (mean age: 64.6±8.6 years). Significant association was observed between blood pressure variability and cognitive decline. Each 10% increment in coefficient of variation of systolic and diastolic blood pressure was associated with accelerated global cognitive decline of 0.026 SD/y (95% CI, 0.016–0.036, P<0.001) and 0.022 SD/y (95% CI, 0.017–0.027, P<0.001), respectively. Nonlinear dose-response relationship was found (P<0.001 for nonlinearity), with clear turning point observed (P<0.001 for change in slopes).

Conclusions: Higher long-term blood pressure variability was associated with accelerated cognitive decline among general adults aged ≥50 years, with nonlinear dose-response relationship. Further randomized controlled trials are warranted to evaluate potential benefits of blood pressure variability-lowering strategies from a cognitive health perspective.

Keywords: blood pressure; cognitive decline; hypertension; longitudinal studies; retirement.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aging
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure*
  • Cognitive Dysfunction / epidemiology
  • Cognitive Dysfunction / physiopathology*
  • England / epidemiology
  • Female
  • Humans
  • Hypertension / complications
  • Linear Models
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Surveys and Questionnaires

Substances

  • Antihypertensive Agents